Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (261-270 of 443) with videos related to

Pageof 45
Sort By:
Journal of Hematology & Oncology|March 17, 2016
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMTMarie T Rubio, Bipin N Savani, Myriam Labopin, et al.
Cancer|December 17, 2013
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMoshe Yeshurun, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|January 7, 2023
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSebastian Giebel, Myriam Labopin, Mohamed Houhou, et al.
Blood Advances|January 4, 2018
The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxisFrancesca Lorentino, Myriam Labopin, Katharina Fleischhauer, et al.
Haematologica|February 23, 2019
Sorafenib improves survival of <i>FLT3</i>-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Giorgia Battipaglia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2015
Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated DonorsClaire Calmettes, Stéphane Vigouroux, Myriam Labopin, et al.
Blood Advances|July 16, 2025
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemiaXavier Poire, Myriam Labopin, Emmanuelle Polge, et al.
American Journal of Hematology|March 10, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMTJordi Esteve, Arnon Nagler, Myriam Labopin, et al.
Bone Marrow Transplantation|June 1, 2019
Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMTAnnalisa Ruggeri, Myriam Labopin, Bipin Savani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 4, 2020
Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell TransplantationAlexis Genthon, Eolia Brissot, Florent Malard, et al.
Pageof 45

Showing results (261-270 of 443) with videos related to

Sort By:
Pageof 45
Journal of Hematology & Oncology|March 17, 2016
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMTMarie T Rubio, Bipin N Savani, Myriam Labopin, et al.
Cancer|December 17, 2013
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMoshe Yeshurun, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|January 7, 2023
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSebastian Giebel, Myriam Labopin, Mohamed Houhou, et al.
Blood Advances|January 4, 2018
The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxisFrancesca Lorentino, Myriam Labopin, Katharina Fleischhauer, et al.
Haematologica|February 23, 2019
Sorafenib improves survival of <i>FLT3</i>-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Giorgia Battipaglia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2015
Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated DonorsClaire Calmettes, Stéphane Vigouroux, Myriam Labopin, et al.
Blood Advances|July 16, 2025
Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemiaXavier Poire, Myriam Labopin, Emmanuelle Polge, et al.
American Journal of Hematology|March 10, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMTJordi Esteve, Arnon Nagler, Myriam Labopin, et al.
Bone Marrow Transplantation|June 1, 2019
Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMTAnnalisa Ruggeri, Myriam Labopin, Bipin Savani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 4, 2020
Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell TransplantationAlexis Genthon, Eolia Brissot, Florent Malard, et al.
Pageof 45